Physician profile
Christopher D Combs
NPI 1679604441
$5,581.47
in general payments reported to CMS, 2019-2025
47 companies · $683 in 2025
The $683 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $708 · 2021: $1,115 · 2022: $1,042 · 2023: $1,002 · 2024: $801 · 2025: $683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,485.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $911.91 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Lilly USA, LLC | $543.07 | 2019-2024 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals Lp | $480.46 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $476.42 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $447.21 | 2020-2025 | |
| Novo Nordisk INC | $416.71 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $261.38 | 2019-2025 | Repatha, Otezla, Otezla |
| Takeda Pharmaceuticals U.S.A., INC. | $244.76 | 2019-2024 | Trintellix |
| Abbott Laboratories | $153.29 | 2022-2023 | Freestyle Libre 3, Freestyle Libre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.88 | 2020-2023 | Jardiance |
| Allergan, INC. | $137.03 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $127.85 | 2019-2024 | Capvaxive, Gardasil, Gardasil 9 |
| Exact Sciences Corporation | $109.75 | 2023-2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $104.22 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $79.72 | 2020-2021 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Combs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.